Pharmadrug Inc. (PHRX.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.2 Million CAD | -14.67% |
| 2022 | 1.41 Million CAD | 1643.5% |
| 2021 | -91.61 Thousand CAD | 90.92% |
| 2020 | -1 Million CAD | -133.1% |
| 2019 | 3.04 Million CAD | 278.62% |
| 2018 | 805.08 Thousand CAD | -21.97% |
| 2017 | 1.03 Million CAD | 778.84% |
| 2016 | 117.39 Thousand CAD | 327.75% |
| 2015 | -51.54 Thousand CAD | 95.41% |
| 2014 | -1.12 Million CAD | -619.37% |
| 2013 | -156.1 Thousand CAD | 82.01% |
| 2012 | -867.93 Thousand CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.2 Million CAD | 18.17% |
| 2024 Q1 | 1.01 Million CAD | -15.73% |
| 2023 Q3 | 1.44 Million CAD | -7.87% |
| 2023 Q2 | 1.56 Million CAD | 12.99% |
| 2023 Q4 | 1.2 Million CAD | -16.35% |
| 2023 FY | 1.2 Million CAD | -14.67% |
| 2023 Q1 | 1.38 Million CAD | -2.0% |
| 2022 Q1 | 804.69 Thousand CAD | 978.33% |
| 2022 Q3 | 1.37 Million CAD | 61.24% |
| 2022 Q4 | 1.41 Million CAD | 3.16% |
| 2022 FY | 1.41 Million CAD | 1643.5% |
| 2022 Q2 | 850.16 Thousand CAD | 5.65% |
| 2021 Q2 | -2.02 Million CAD | 24.41% |
| 2021 Q4 | -91.61 Thousand CAD | 90.51% |
| 2021 FY | -91.61 Thousand CAD | 90.92% |
| 2021 Q1 | -2.67 Million CAD | -165.31% |
| 2021 Q3 | -965.1 Thousand CAD | 52.31% |
| 2020 Q1 | 2.75 Million CAD | -9.57% |
| 2020 Q2 | 1.57 Million CAD | -42.86% |
| 2020 Q3 | 1.52 Million CAD | -2.98% |
| 2020 Q4 | -1 Million CAD | -166.03% |
| 2020 FY | -1 Million CAD | -133.1% |
| 2019 Q2 | 3.37 Million CAD | 243.23% |
| 2019 Q4 | 3.04 Million CAD | 20.61% |
| 2019 FY | 3.04 Million CAD | 278.62% |
| 2019 Q1 | 984.54 Thousand CAD | 22.29% |
| 2019 Q3 | 2.52 Million CAD | -25.21% |
| 2018 FY | 805.08 Thousand CAD | -21.97% |
| 2018 Q4 | 805.08 Thousand CAD | 105.19% |
| 2018 Q3 | 392.35 Thousand CAD | -65.59% |
| 2018 Q2 | 1.14 Million CAD | 5.27% |
| 2018 Q1 | 1.08 Million CAD | 5.24% |
| 2017 Q1 | -10.05 Thousand CAD | -39.97% |
| 2017 Q2 | -22.35 Thousand CAD | -122.29% |
| 2017 Q3 | -1068.00 CAD | 95.22% |
| 2017 Q4 | 1.02 Million CAD | 96464.98% |
| 2017 FY | 1.03 Million CAD | 778.84% |
| 2016 Q1 | -11.91 Thousand CAD | -88.37% |
| 2016 FY | 117.39 Thousand CAD | 327.75% |
| 2016 Q3 | -12.58 Thousand CAD | -184.77% |
| 2016 Q2 | -4419.00 CAD | 62.92% |
| 2016 Q4 | -7186.00 CAD | 42.9% |
| 2015 Q1 | -367.77 Thousand CAD | 40.57% |
| 2015 Q4 | -6326.00 CAD | 87.73% |
| 2015 FY | -51.54 Thousand CAD | 95.41% |
| 2015 Q2 | -136.52 Thousand CAD | 62.88% |
| 2015 Q3 | -51.54 Thousand CAD | 62.24% |
| 2014 Q1 | -1.45 Million CAD | -26.1% |
| 2014 FY | -1.12 Million CAD | -619.37% |
| 2014 Q2 | -1.14 Million CAD | 21.47% |
| 2014 Q3 | -1.12 Million CAD | 1.6% |
| 2014 Q4 | -618.8 Thousand CAD | 44.9% |
| 2013 FY | -156.1 Thousand CAD | 82.01% |
| 2013 Q2 | -180.52 Thousand CAD | 25.3% |
| 2013 Q1 | -241.66 Thousand CAD | 19.47% |
| 2013 Q3 | -156.1 Thousand CAD | 13.53% |
| 2013 Q4 | -1.15 Million CAD | -638.23% |
| 2012 Q1 | -894.54 Thousand CAD | -33.87% |
| 2012 Q2 | -877.85 Thousand CAD | 1.87% |
| 2012 Q3 | -867.93 Thousand CAD | 1.13% |
| 2012 Q4 | -300.07 Thousand CAD | 65.43% |
| 2012 FY | -867.93 Thousand CAD | 0.0% |
| 2011 Q4 | -668.22 Thousand CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.13 Thousand CAD | -46.065% |
| Ayurcann Holdings Corp. | 69.97 Thousand CAD | -1624.363% |
| Blueberries Medical Corp. | -805.35 Thousand CAD | 249.834% |
| The BC Bud Corporation | 225.15 Thousand CAD | -435.943% |
| BioNxt Solutions Inc. | 4.53 Million CAD | 73.365% |
| CordovaCann Corp. | 6.13 Million CAD | 80.318% |
| Christina Lake Cannabis Corp. | 4.62 Million CAD | 73.927% |
| Captor Capital Corp. | -5.41 Million CAD | 122.303% |
| City View Green Holdings Inc. | 1.49 Million CAD | 19.459% |
| 1CM Inc. | 3.31 Million CAD | 63.599% |
| Global Hemp Group Inc. | 3.55 Million CAD | 66.029% |
| Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | 91.672% |
| IM Cannabis Corp. | 11.96 Million CAD | 89.918% |
| Lobe Sciences Ltd. | 192.35 Thousand CAD | -527.342% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | 51.223% |
| Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 120.401% |
| Nextleaf Solutions Ltd. | -449.15 Thousand CAD | 368.659% |
| Ovation Science Inc. | 143.76 Thousand CAD | -739.344% |
| Captiva Verde Wellness Corp. | 186.26 Thousand CAD | -547.854% |
| RAMM Pharma Corp. | -4.71 Million CAD | 125.611% |
| RIV Capital Inc. | -101.38 Million CAD | 101.19% |
| Revive Therapeutics Ltd. | -797.85 Thousand CAD | 251.243% |
| Red White & Bloom Brands Inc. | 259.87 Million CAD | 99.536% |
| SLANG Worldwide Inc. | 20.83 Million CAD | 94.207% |
| 1933 Industries Inc. | 16.47 Million CAD | 92.677% |
| Red Light Holland Corp. | -13.56 Million CAD | 108.898% |
| Top Strike Resources Corp. | 13.24 Million CAD | 90.892% |
| Xebra Brands Ltd. | -102.41 Thousand CAD | 1278.203% |
| Adastra Holdings Ltd. | 2.2 Million CAD | 45.258% |